台股 » 東生華 » 個股財報 » 每月營收

東生華

(8432)
可現股當沖
  • 股價
    64.8
  • 漲跌
    ▲0.1
  • 漲幅
    +0.15%
  • 成交量
    78
  • 產業
    上櫃 生技醫療類股 ▲0.18%
  • 本地時間:13:30(已收盤)

    36人加入追蹤

    立即追蹤

東生華 (8432) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

東生華 (8432) 月營收分析比較圖

東生華 (8432) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2024/09222,334159,916150.5%39%824,215584,55741%
2024/0888,76660,99715.2%45.5%601,881424,64141.7%
2024/0777,03448,50610.7%58.8%513,115363,64441.1%
2024/0669,57167,111-23.3%3.7%436,081315,13838.4%
2024/0590,74254,99220.5%65%366,510248,02647.8%
2024/0475,27748,17744.7%56.3%275,768193,03542.8%
2024/0352,00752,44051.3%-0.8%200,491144,85838.4%
2024/0234,37544,700-69.9%-23.1%148,48492,41860.7%
2024/01114,10947,71858.2%139.1%114,10947,718139.1%
2023/1272,12545,61065.8%58.1%811,208464,37874.7%
2023/1143,49038,9864.3%11.6%453,071418,7688.2%
2023/1041,70737,557-1.8%11%409,581379,7827.8%
2023/0942,46941,0394%3.5%367,874342,2257.5%
2023/0840,82936,6541%11.4%325,405301,1868%
2023/0740,41034,463-9.7%17.3%284,576264,5327.6%
2023/0644,77236,0295.9%24.3%244,165230,0696.1%
2023/0542,25436,4876.5%15.8%199,393194,0392.8%
2023/0439,67737,103-4.4%6.9%157,139157,552-0.3%
2023/0341,51642,33919.9%-1.9%117,462120,449-2.5%
2023/0234,63828,121-16.1%23.2%75,94678,110-2.8%
2023/0141,30849,989-9.4%-17.4%41,30849,989-17.4%
2022/1245,61037,10517%22.9%464,378413,48312.3%
2022/1138,98636,2003.8%7.7%418,768376,37811.3%
2022/1037,55734,287-8.5%9.5%379,782340,17811.6%
2022/0941,03935,30312%16.2%342,225305,89111.9%
2022/0836,65433,9756.3%7.9%301,186270,58811.3%
2022/0734,46329,572-4.3%16.5%264,532236,61311.8%
2022/0636,02933,597-1.3%7.2%230,069207,04111.1%
2022/0536,48736,620-1.7%-0.4%194,039173,44411.9%
2022/0437,10335,077-12.4%5.8%157,552136,82415.1%
2022/0342,33938,89950.6%8.8%120,449101,74718.4%
2022/0228,12126,133-43.7%7.6%78,11062,84924.3%
2022/0149,98936,71534.7%36.2%49,98936,71536.2%
2021/1237,10548,3322.5%-23.2%413,483447,862-7.7%
2021/1136,20035,2365.6%2.7%376,378399,531-5.8%
2021/1034,28741,304-2.9%-17%340,178364,295-6.6%
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華法說會/併購高峰、三大業務加持 今年營收拚增五成達12億UDN聯合新聞網-2024/03/25
東生華 相關文章